Future Medicinal Chemistry, 4(12), 1527-1531
Samples were prepared with TA (30, 150, and 300 g/mL) [26], EDTA (100, 500, and 1000 g/mL) [27], and AA (10, 50, and 100 g/mL) [28] due to their applications in reducing oxidation and scavenging free radicals in both ophthalmic and non-ophthalmic settings
Because both BPC-157 and TB-500 possess distinct mechanisms, durations of action, and biological targets, establishing a rational dosing structure requires looking beyond anecdotal commentary and into preclinical data
A step in this direction would be a treatment strategy designed to offset neuron losses by stimulating synaptogenesis in existing neurons and the formation of new functional neurons thus slowing disease progression
J.NolteI
Depending on your case, you may be prescribed injectable or oral anticoagulants or both